by Alex Watkins ONeill | Aug 1, 2023 | Content
Recently released federal data shows U.S. consumption of alcohol, which had already been increasing for years, accelerated during the pandemic as Americans grappled with stress and isolation. At the same time, the number of deaths caused by alcohol skyrocketed...
by Alex Watkins ONeill | Jul 26, 2023 | Content
While the federal government eliminated the DATA-X Waiver requirement to prescribe medication for opioid use disorder (MOUD) last year, there is an additional requirement that controlled medication prescribers must receive at least 8 hours of education on treating and...
by Alex Watkins ONeill | Jul 25, 2023 | Content
The Injury and Violence Prevention Branch of the Division of Public Health (IVPB) recently posted an update of suspected overdose deaths, provisional data on ED visits for overdose and fentanyl-positive deaths report. Suspected Overdose Deaths There were 368 suspected...
by Alex Watkins ONeill | Jul 19, 2023 | Content
Mental health issues are common – more than 1 in 5 US adults live with a mental illness. Mental health issues are treatable and often preventable, but not everyone has access to the resources they need. People in some racial and ethnic minority groups face more...
by Alex Watkins ONeill | Jul 17, 2023 | Content
This study discusses the evidence regarding buprenorphine dosing, noting the Food and Drug Administration’s (FDA) product label target dose of 16 mg/d. Early dose recommendations were based on mu receptor occupancy, and FDA buprenorphine literature states occupancy...
by Alex Watkins ONeill | Jul 4, 2023 | Content
This study used data from the Longitudinal Prescription Database, which includes 92% of retail prescriptions in the US, to calculate rates of initiation of buprenorphine treatment and treatment retention (180 days or more of continuous treatment). Researchers were...
Recent Comments